BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1580116)

  • 21. Video-assisted management of malignant pleural effusion in breast carcinoma.
    Gasparri R; Leo F; Veronesi G; De Pas T; Colleoni M; Maisonneuve P; Pelosi G; Galimberti V; Spaggiari L
    Cancer; 2006 Jan; 106(2):271-6. PubMed ID: 16342163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
    Kang M; Zhou L; Lin P
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoperoxidase staining of malignant cells in pleural effusions.
    Pastormerlo M
    Pathologica; 1990; 82(1080):421-5. PubMed ID: 2284143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diffuse malignant mesothelioma. Presentation of 10 cases and review of the literature].
    Briceño CE; Bértoli F; Echavarría A
    Rev Med Panama; 1990 Sep; 15(3):168-75. PubMed ID: 2284446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Extensive pulmonary tumor embolisms of anaplastic thyroid gland carcinoma as a rare cause of hemorrhagic pleural effusion in an 88-year-old patient].
    Köppl H; Scheer E; Herbst EW
    Pneumologie; 1993 Oct; 47(10):593-6. PubMed ID: 8259368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytological exam of the pleural fluid in the diagnosis of neoplastic pleuritis. Cases contribution].
    Vignale L; Galli G; Rossi PC; Parentini GC
    Minerva Med; 1990 Jun; 81(6):455-9. PubMed ID: 2359501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intrapulmonary tumor cell spread and intraoperative pleural lavage as prognostic factors in bronchial carcinoma?].
    Buhr J; Berghäuser KH; Gonner S; Schäffer R; Padberg WM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():798-804. PubMed ID: 9101992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thoracoscopic video-assisted talcum pleurodesis (TTP)--effective treatment of malignant pleural effusion].
    Brünagel G; Decker P; Manekeller S; Hirner A
    Zentralbl Chir; 2002 May; 127(5):453-5. PubMed ID: 12058308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [VATS in malignant pleural effusions].
    Cui Y; Wang J; Liu T
    Zhonghua Wai Ke Za Zhi; 1997 Nov; 35(11):675-6. PubMed ID: 10678010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant pleural and pericardial effusion in invasive breast cancer: impact of the site of the primary tumor.
    Pokieser W; Cassik P; Fischer G; Vesely M; Ulrich W; Peters-Engl C
    Breast Cancer Res Treat; 2004 Jan; 83(2):139-42. PubMed ID: 14997044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The results of some cytochemical reactions in metastatic malignant tumor cells in pleural and peritoneal effusions.
    Bauer Z; Milíc N; Handl S; Koprcina M
    Acta Cytol; 1977; 21(1):141-6. PubMed ID: 264748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic proximal epithelioid sarcoma in pleural effusion: cytopathologic findings and differential diagnosis.
    Guan H; Haque F; Ali SZ
    Diagn Cytopathol; 2013 Jun; 41(6):542-5. PubMed ID: 21953993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant pleural effusion as the presenting site of cancer: comparison with metastatic pleural effusions from known cancers].
    Cellerin L; Marcq M; Sagan C; Chailleux E
    Rev Mal Respir; 2008 Nov; 25(9):1104-9. PubMed ID: 19106906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelioid hemangioendothelioma of the lung: pleural effusion cytology, ultrastructure, and brief literature review.
    Buggage RR; Soudi N; Olson JL; Busseniers AE
    Diagn Cytopathol; 1995 Jul; 13(1):54-60. PubMed ID: 7587877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients.
    Johnston WW
    Cancer; 1985 Aug; 56(4):905-9. PubMed ID: 4016683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effusion cytology in aged patients with malignancy].
    Koike N
    Nihon Ronen Igakkai Zasshi; 1991 Jan; 28(1):46-51. PubMed ID: 2046165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correspondence re: Kent Bottles, Mary J. Reznicek, Elizabeth A. Holly, David K. Ahn, Lester J. Layfield and Michael B. Cohen. Cytologic criteria used to diagnose adenocarcinoma in pleural effusions. Mod Pathol 4:677, 1991.
    Ganjei P
    Mod Pathol; 1992 May; 5(3):353-4. PubMed ID: 1495941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.